CoChat

Mechanisms of Mitochondrial Dysfunction in Alzheimer’s Disease

Cadonic, Chris, Sabbir, Mohammad Golam, Albensi, Benedict C. · 2016 · Molecular Neurobiology

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

Mitochondria are the primary source for energy generation in the cell, which manifests itself in the form of the adenosine triphosphate (ATP). Nicotinamide dinucleotide (NADH) molecules are the first to enter the so-called electron transport chain or ETC of the mitochondria. The ETC represents a chain of reducing agents organized into four major protein-metal complexes (I-IV) that utilize the flow of electrons to drive the production of ATP. An additional integral protein that is related to oxidative phosphorylation is ATP synthase, referred to as complex V. Complex V carries out ATP synthesis as a result of the electron flow through the ETC. The coupling of electron flow from NADH to molecular oxygen to the production of ATP represents a process known as oxidative phosphorylation. In this review, we describe mainly the bioenergetic properties of mitochondria, such as those found in the ETC that may be altered in Alzheimer's disease (AD). Increasing evidence points to several mitochondrial functions that are affected in AD. Furthermore, it is becoming apparent that mitochondria are a potential target for treatment in early-stage AD. With growing interest in the mitochondria as a target for AD, it has been hypothesized that deficit in this organelle may be at the heart of the progression of AD itself. The role of mitochondria in AD may be significant and is emerging as a main area of AD research.

Overview

Integrity signals

Registry

Crossref · 10.1007/s12035-015-9515-5

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 43 references

Research works printed but not linked: 2

  1. Nicholls D, Ferguson S (2013) Bioenergetics, 4th edn. Elsevier
  2. Esteves AR, Arduino DM (2009) “Mitochondrial metabolism in age-related neurodegenerative disorders: Alzheimer’s and Parkinson’s revisited.” In: Svensson OL (ed.) Mitochondria: structure, functions and dysfunctions

Cited by

See all 252

Metadata

Authors
Cadonic, C., Sabbir, M. G., & Albensi, B. C.
Affiliations
St. Boniface Hospital (CA)
Corresponding author
  • Cadonic, Chris
  • Albensi, Benedict C.
Venue
Molecular Neurobiology
Published
2015-11-04
Volume
53
Issue
9
Pages
6078-6090
ISSN
  • 0893-7648 (ISSN-L)
  • 1559-1182
OpenAlex
W2223865021
Cited by
226
References
43
Citations by year
2026: 14 · 2025: 17 · 2024: 11 · 2023: 23 · 2022: 29 · 2021: 32 · 2020: 28 · 2019: 31 · 2018: 20 · 2017: 15 · 2016: 5
FWCI
1.29
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Molecular Neurobiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Natural Sciences and Engineering Research Council of Canada (CA)
  • St.Boniface General Hospital Research Foundation (CA)
  • The University of Manitoba (CA)
  • The Everett Endowment Fund (CA)
  • The Edwards Family Endowment (CA)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
mitochondrial dysfunction, Alzheimer's disease, electron transport chain, oxidative phosphorylation, ATP synthase, mitochondrial bioenergetics, NADH, mitochondrial-targeted therapy, neurodegeneration
MeSH terms
Alzheimer Disease, Animals, Electron Transport, Energy Metabolism, Humans, Mitochondria, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanisms of Mitochondrial Dysfunction in Alzheimer’s Disease. https://app.cochat.ai/papers/10.1007/s12035-015-9515-5
The paper
Cadonic, C., Sabbir, M. G., & Albensi, B. C. (2016). Mechanisms of Mitochondrial Dysfunction in Alzheimer’s Disease. Molecular Neurobiology. https://doi.org/10.1007/s12035-015-9515-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.